As materials with permanently porous structures and readily modifying availability, porous aromatic frameworks (PAFs) are considered as promising porous materials with versatile functionality. Currently the designable synthesis of PAFs with the desired surface area and pore size is still a challenge, and instead kinetically irreversible coupling reactions for PAFs synthesis has resulted in the unpredictable connection of building units. Herein, a series of PAFs with highly porous and hierarchical structures were successfully synthesized through a multivariate inspired strategy, where multiple building units with various topologies and sizes were selected for PAFs synthesis. All the PAFs synthesized through this strategy possessed hierarchical structures and high specific surface areas at the same time. Encouraged by their high surface area and hierarchical structures, we loaded lipase onto one of the multivariate PAFs. The enzyme loading content of the obtained lipase@PAF-147 was as high as 1456 mg g^-1, which surpassed any other currently reported enzyme loading materials. The lipase@PAF-147 also exhibited favorable catalytic activity and stability to a model reaction of p-nitrophenyl caprylate (p-NPC) hydrolysis. This multivariate strategy inspired synthetic method broadens the selection of building units for PAFs design and opens a new avenue for the design of functional porous materials.

The C-reactive protein/albumin ratio (CRP/Alb ratio) has been reported to have promising prognostic value in several cancers. The current meta-analysis was conducted to better define the prognostic value of CRP/Alb ratio in patients with NPC. The Web of Science, Embase, Cochrane Library databases and PubMed were searched up to February 25, 2018 for the information on CRP/Alb ratio and outcomes of NPC. Pooled hazard ratios (HRs) and corresponding 95% confidence intervals (95% CIs) were used to evaluate the association between CRP/Alb ratio and survival outcomes in NPC. A total of five studies with 5,533 patients with NPC were included. Pooled results showed that high CRP/Alb ratio was associated with poor overall survival (OS) (HR=1.51, 95% CI: 1.30-1.75, P <0.001) and poor distant metastasis-free survival (DMFS) (HR=1.23, 95% CI: 1.07-1.43, P =0.005). Subgroup analyses showed that patients with higher CRP/Alb ratio have worse OS in NPC. In conclusion, elevated CRP/Alb ratio was associated with worse prognosis in patients with NPC.